SB

Sahil Bose

235 comments

Recent Discussions

SB
Sahil Bose6h ago
RESP

Responsive Industries has reported a significant 13% year-over-year increase in their Q4 revenues, reaching ₹4.3 billion compared to ₹3.8 billion in the same quarter last year.

SB
Sahil Bose6h ago
PLAZ

Plaza Wires will present their final year results during a board meeting scheduled for May 29, 2026. Trading restrictions for key personnel will be in place until 48 hours following the announcement of these results.

SB
Sahil Bose6h ago
NEOG

Neogen Chemicals saw a significant 22% year-on-year increase in Q4 revenue to INR 247 crore, thanks to higher volume sales, optimal plant usage, and strategic moves such as expanding into lithium-ion battery materials. The company's EBITDA stood at INR 44 crore with a margin of 17.8%.

SB
Sahil Bose6h ago
ENGI

Engineers India shares rose 5.5% to Rs 227.75 following Q4 results, with Antique keeping a Buy rating and a target price of Rs 256. In contrast, NTPC Green dropped 4.1% to Rs 100.10 post Q4, with Elara suggesting a Sell, while NTPC received a Buy rating from JM Financial.

SB
Sahil Bose6h ago
WIPR

Wipro has seen a steady increase for nine straight days, marking an impressive run in the market. Shareholders should take note that the record date for the company's upcoming buyback plan is scheduled for June 5th.

SB
Sahil Bose6h ago
KEC

KEC International Ltd successfully repaid a ₹100 crore Commercial Paper on May 25, 2026, adhering to SEBI regulations, as previously announced by the company.

SB
Sahil Bose6h ago
CONC

Concor's shares experienced a 4% decline after the release of their Q4 results, indicating a potential need for improvement in the company's performance.

SB
Sahil Bose6h ago
KOPR

Yuga Stocks and Commodities Pvt. Ltd has offloaded approximately 1.76 million shares of Kopran Ltd, with the average selling price set at ₹190.6 in a recent transaction on the National Stock Exchange.

SB
Sahil Bose6h ago
SPAR

SPARC, a clinical-stage biopharmaceutical company, is primarily dedicated to the discovery and development of novel drugs. They also excel in creating advanced drug delivery systems, setting them apart in the pharmaceutical industry. (business-standard.com)

SB
Sahil Bose6h ago
JUBL

Anticipation builds for Jubilant Ingrevia's Q4 financial results, which are set to be released soon. Investors will closely watch these numbers for insights into the company's performance during the quarter.

SB
Sahil Bose1d ago
TITA

Titagarh Rail Systems experienced a notable surge of 7.9%, reaching an intraday peak at Rs 816.45, indicating robust investor demand and superior market performance compared to the overall market.

SB
Sahil Bose1d ago
SKME

Alphagrep has offloaded 318,814 SKM Egg Product shares at an average price of Rs. 212.5 each on the National Stock Exchange. This significant transaction may indicate a strategic move or market adjustment by the company.

SB
Sahil Bose1d ago
CENT

Centrum Capital experienced a 1.96% decline to close at Rs.23.05, underperforming the Sensex's 0.5% gain due to bearish momentum following a technical downgrade and mixed Q4 results that pointed to underlying structural issues.

SB
Sahil Bose3d ago
COLP

Colgate's Q4 sales exceeded forecasts, leading to the announcement of a significant ₹24 dividend payout to its shareholders. The company's impressive performance underscores its strong financial health.

SB
Sahil Bose3d ago
INDI

The Delhi High Court has provided temporary relief to IndiGo, exempting them from a 458 crore GST demand related to engine compensation. This decision could potentially establish a significant precedent for future GST disputes, as IndiGo contends that such compensations should not be subject to taxation.

SB
Sahil Bose3d ago
DATA

Data Patterns (India) Ltd has reported a significant jump in FY26 revenue by 31% Year-over-Year, reaching INR 925 crore. EBITDA also saw an increase of 35%. Additionally, order inflows surged by 216% YoY to INR 1,121 crore, and the order book currently stands at INR 2,062 crore, indicating a strong revenue outlook for the future.

SB
Sahil Bose3d ago
WIND

Windlas Biotech has released the audio recording of their Q4 FY26 results, with a detailed transcript expected soon. The discussion encompasses their financial performance, offering insights for both investors and analysts.

SB
Sahil Bose3d ago
SHIL

Shilpa Medicare has finalized its FY25-26 financial reports, receiving an unqualified assessment from the auditor. Shareholders are set to receive a dividend of ₹0.60 per share. The company also appointed new auditors and acquired a 28% stake in a renewable energy firm.

SB
Sahil Bose3d ago
GODA

Godavari Biorefineries experienced a decrease in profit after tax (PAT) by 26.5% year-over-year in Q4 FY26, dropping to INR 52.9 crore, and there was also a slight reduction in overall revenue compared to the previous year. The decline continued with EBITDA dropping 24.3% YoY to INR 92.1 crore.

SB
Sahil Bose4d ago
AURO

Aurobindo Pharma's subsidiary Agile Pharma BV has established a new company, Arrow Pharma Production SAS in France. This new entity will specialize in the production of generic pharmaceuticals and is entirely owned by Aurobindo with an initial investment of €100K.

SB
Sahil Bose4d ago
ITC

ITC's revenue experienced a notable 17% increase, with their consumer goods segment outperforming, compensating for the impact of cigarette taxes.

SB
Sahil Bose4d ago
JUNI

Juniper Hotels has announced their financial results for the fiscal year 2026, affirming a successful performance. The Chairman and Managing Director have been reappointed for another three-year term. Additionally, they have completed the full acquisition of Juniper Hospitality's assets, as attested by the auditor with an unmodified opinion.

SB
Sahil Bose4d ago
AXIS

In the financial year 2026, private banks encountered a decline in their return on equity due to compressed net interest margins and losses from treasury operations. Notable banks like ICICI Bank, Axis Bank, HDFC Bank, and Kotak Mahindra experienced profitability hurdles as a result.

SB
Sahil Bose4d ago
NYKA

Today, Aurobindo Pharma, Nykaa, Hindalco, GAIL, and LIC are attracting attention due to the upcoming Q4 results and associated news updates, potentially influencing market action.

SB
Sahil Bose4d ago
LICI

Life Insurance Corporation (LIC) has announced a 1:1 bonus issue. Shareholders' records as of May 29 will be crucial for eligibility.

SB
Sahil Bose4d ago
QUIC

Quick Heal Technologies experienced a significant drop of 6.6%, trading at 197.2, due to negative market indicators. Notably, financial analysts at MarketsMojo have downgraded the stock to 'Strong Sell' due to its underperformance compared to its sector for the day.

SB
Sahil Bose4d ago
HNDF

Hindustan Foods shows a significant increase in quarterly profits by 31.7% Year-over-Year, along with a 27.5% rise in EBITDA, signaling strong financial performance for the company.

SB
Sahil Bose4d ago
NAVN

Navneet Education maintained its Q4 revenue at approximately INR 394 crores, yet faced challenges in FY26 as revenue dropped to around INR 1683 crores. Declining exports, increased tariffs, GST, and stiff competition appear to have impacted profitability.

SB
Sahil Bose4d ago
SUNP

Sun Pharma is projected to experience a significant 28% increase in quarterly profits, largely due to robust global specialty sales. The company's Q4 earnings are expected to reflect this positive trend.

SB
Sahil Bose5d ago
YESB

The Supreme Court has paused its decision on the disputed write-down of Yes Bank's AT1 bonds worth approximately Rs 8415 crores, as they review the legality of the bank's 2020 rescue measures. The potential outcome could have significant implications for the Rs 1 lakh crore AT1 bond market, potentially affecting investor confidence and future banking interventions.

SB
Sahil Bose5d ago
JKPA

JK Paper reported a significant 17% year-on-year revenue growth in Q4, with total income reaching approximately INR 1966 crores. Consequently, shares of the company surged by 7%.

SB
Sahil Bose5d ago
APOL

Apollo Tyres Ltd shares plummeted to a 52-week low of Rs 365.35, marking a significant 32.3% drop from its high of Rs 540.30. Despite positive financial indicators, the stock is currently in a sell-off trend.

SB
Sahil Bose5d ago
IGPL

IG Petrochemicals reported a significant increase of 38% in Q4 EBITDA for FY26, reaching INR 75 Cr against INR 530 Cr revenue. The company also announced a dividend of INR 5 per share and completed its plasticizer plant in March 2026.

SB
Sahil Bose5d ago
POWE

Power Mech Projects announces a final dividend of ₹1.5 per share for the fiscal year 2026, subject to shareholder approval at the upcoming AGM. The dividend will be distributed within 30 days post-approval.

SB
Sahil Bose5d ago
JUBL

Aditya Birla Capital has authorized a ₹4,000 crore equity issue for expansion, while Bosch India records a robust Q4 due to increased auto demand. Meanwhile, Dr. Reddy's introduces an oral semaglutide biosimilar, but Jubilant FoodWorks and Whirlpool report declining profits in their latest quarters.

SB
Sahil Bose5d ago
MANI

Man Industries has strengthened its global reach and expanded its operations in the Middle East by acquiring Saudi Arabia's National Pipe Company for approximately $102 million (₹1,000 Crore). This acquisition significantly increases Man Industries' pipe manufacturing capacity, now boasting 430,000 MT.

SB
Sahil Bose5d ago
APOL

Apollo Hospitals predicts that their Kolkata facility will become profitable within the next year, due to an accelerated growth in operations following its expansion.

SB
Sahil Bose5d ago
PAGE

Page Industries experienced its best quarterly volume growth in three years, with strong sales performance in Q4. Shareholders can look forward to receiving a ₹150 dividend as a result of the company's success.

SB
Sahil Bose6d ago
TVSS

TVS Srichakra will convene a board meeting on May 27, 2026, to discuss and announce their audited financial results for the fiscal year ended March 31, 2026. The meeting will also cover the recommendation for dividends for this period.

SB
Sahil Bose6d ago
BEL

The Nifty index is finding resistance at its 50-day moving average, with the IT sector showing a 6% growth. Pivotal results from companies like Apollo Hospitals, Grasim, BEL, BPCL, and IRB Infra are expected to shape market direction.